November 18, 2022

Get Irked - Investments in Play - November 18, 2022

Click above image for larger version

The Week’s Biggest Winner & Loser

Visa (V)

Visa (V), it’s everywhere you want to be… including being the Biggest Winner of the Week with a +2.83% gain. Sure, that’s not huge, but the big V brought in more than any other position in the portfolio, and that’s the name of the weekly game.

Coinbase (COIN)

As the cryptocurrency sector continued to implode with one horrifying revelation after another decimating the sector, no company in the space was safe, including Coinbase (COIN), which dropped a whopping -21.23% after investors and traders fled the space when investigations revealed that major crypto brokerage FTX was a gigantic scam, taking its users’ funds and making outrageously bad bets with them.

Portfolio Allocation

Click charts for enlarged versions

Positions

%

Target Position Size

Get Irked - Investments in Play - Current Holdings - November 18, 2022

Click above image for larger version

Portfolio Breakdown

Get Irked - Year-to-Date Performance - Investments in Play vs. Speculation in Play - 2022 Year-to-Date Performance

Click above image for larger version

Year-to-Date Performance

The “Baskets”

The Investments in Play portfolio contains a number of groups of stocks called “baskets.” I use baskets when I want exposure to a certain sector, but I want to use more than one stock to get that exposure without giving each individual stock an allocation.

In this portfolio, there is the Financials Basket which includes stocks that provide the portfolio with exposure to the financial sector which includes money-center banks, credit card companies, and investment management firms.

The Pets Basket includes the two leaders in pet health, long-time holding IDEXX Labs (IDXX) and newcomer Zoetis (ZTS). Both are considered “Best-in-Breed” (pun intended) for different reasons which is why I’m holding both of them instead of just picking one or over the other.

Additionally, there are two speculative baskets in the portfolio: Old-Spec and New-Spec.

Companies in the Old-Spec basket are ones with long track records where I want to have some exposure in the portfolio but I’m not confident enough to give each a full allocation.

New-Spec companies are typically stocks either new on the scene or representing a fairly new approach or sector, where, like Old-Spec, I want exposure but I don’t want a full allocation of any individual company.

Current Position Performance

Apple (AAPL)

+824.76%*

1st Buy 4/18/2013 @ $14.17
Current Per-Share: (-$60.81)*

Boeing (BA)

+617.64%*

1st Buy 2/14/2012 @ $79.58
Current Per-Share: (-$162.30)*

Nvidia (NVDA)

+586.27%*

1st Buy 9/6/2016 @ $15.77
Current Per-Share:  (-$5.75)*

Block (SQ)

+520.49%*

1st Buy 8/5/2016 @ $11.10
Current Per-Share: (-$75.30)*

Tesla (TSLA)

+482.64%*

1st Buy 3/12/2020 @ $37.10
Current Per-Share: (-$26.14)*

Logitech (LOGI)

+403.143

1st Buy 11/11/2016 @ $24.20
Current Per-Share: $11.71

Nike (NKE)

+410.05%*

1st Buy 2/14/2012 @ $26.71
Current Per-Share: (-$6.70)*

IDEXX Labs (IDXX)

+384.56%*

1st Buy 7/26/2017 @ $167.29
Current Per-Share: (-$112.25)*

Skyworks (SWKS)

+335.23%*

1st Buy 1/31/2020 @ $113.60
Current Per-Share: (-$20.20)*

Disney (DIS)

+201.68%

1st Buy 2/14/2012 @ $41.70
Current Per-Share: $30.45

JP Morgan (JPM)

+98.24%

1st Buy 10/26/2017 @ $102.30
Current Per-Share: $67.55

Berkshire (BRK.B)

+65.04%

1st Buy 8/2/2019 @ $199.96
Current Per-Share: $187.77

Meta (META)

+54.61%*

1st Buy 9/16/2017 @ $128.58
Current Per-Share: -($64.60)*

Dow (DOW)

+53.43%

1st Buy 5/13/2019 @ $53.18
Current Per-Share: $32.65

Amazon (AMZN)

+30.39%

1st Buy 2/6/2018 @ $69.15
Current Per-Share: $72.20

Salesforce (CRM)

+29.05%

1st Buy 6/11/2018 @ $134.05
Current Per-Share: $114.75

Take Two (TTWO)

+27.26%

1st Buy 10/9/2018 @ $128.40
Current Per-Share: $77.61

Morgan Stan (MS)

+23.42%

1st Buy 4/25/2022 @ $83.50
Current Per-Share: $72.27

Visa (V)

+20.51%

1st Buy 5/9/2022 @ $194.00
Current Per-Share: $175.00

Schwab (SCHW)

+11.47%

1st Buy 4/18/2022 @ $76.30
Current Per-Share: $71.60

Alphabet (GOOGL)

+0.50%

1st Buy 9/16/2022 @ $101.93
Current Per-Share: $96.95

Zoetis (ZTS)

-3.16%

1st Buy 6/13/2022 @ $157.55
Current Per-Share: $150.40

Dutch Bros (BROS)

-6.91%

1st Buy 9/20/2021 @ $42.25
Current Per-Share: $36.60

Roblox (RLBX)

-31.14%

1st Buy 9/29/2021 @ $77.00
Current Per-Share: $46.05

Canopy (CGC)

-34.68%

1st Buy 5/24/2018 @ $29.53
Current Per-Share: $5.62

Twilio (TWLO)

-48.34%

1st Buy 8/8/2019 @ $125.71
Current Per-Share: $95.35

Rivian (RIVN)

-48.92%

1st Buy 11/12/2021 @ $127.00
Current Per-Share: $59.40

Coinbase (COIN)

-78.68%

1st Buy 4/14/2021 @ $412.47
Current Per-Share: $212.34

* Indicates a position where the capital investment was sold.
Profit % for * positions = Total Profit / Starting Capital Investment

A negative share price indicates the dollar amount of profit for each share currently held.

This Week’s Moves

Block (SQ): Profit-Taking

When Block (SQ) struggled to rise above its high from last week on Monday, I decided it was take profits with a sell order that filled at $71.08, locking in +15.11% in gains on shares I bought for $61.75 on June 14.

The sale lowered my per-share “cost” -5.39% from -$71.45 to -$75.30 (a negative per-share cost indicates all capital has been removed in addition to $75.30 per share added to the portfolio’s bottom line in addition to each share’s current value).

From here, my next sell target is just under $92.00, a past point of resistance, and my next buy target is $52.10, slightly higher than SQ’s 2022 low of $51.34.

SQ closed the week at $65.80, down -7.43% from where I took profits Monday.

JPMorgan Chase (JPM): Profit-Taking

The banks continued the rally started last week with JPMorgan Chase (JPM) crossing through my next sell target which filled on Monday at $135.63. The sale locked in +5.73% in gains on shares I bought for $128.28 on March 8, and lowered my per-share cost -6.74% from $72.43 to $67.55.

From here, my next sell target is $157.80, around a past point of resistance, and my next buy target is $101.75, above JPM’s 2022 low at $101.28.

JPM closed the week at $133.91, down -1.27% from where I took profits Monday.

Morgan Stanley (MS): Profit-Taking

When the market rallied on Tuesday following the better-than-feared Producer Price Index (PPI) report, Morgan Stanley (MS) triggered my next sell order which filled at $91.29, locking in +13.05% in gains on shares I bought for $80.75 on May 9.

The sale lowered my per-share cost -4.63% from $76.75 to $73.20. On Wednesday, Morgan Stanley paid out its quarterly dividend which, after reinvestment, lowered my per-share cost an additional -1.27% from $73.20 to $2.27.

From here, my next sell target is slightly below MS’s all-time high at $109.25, and my next buy target is $72.15, slightly above Morgan Stanley’s 2022 low of $72.05.

MS closed the week at $89.20, down -2.29% from where I took profits Tuesday.

Want Further Clarification?

As always, if you have questions about any of my positions or have positions of your own that you’re curious about – feel free to leave a comment below!

See you next week!

Don't get mad, Get Irked and learn how to invest for yourself!

 

Get Irked is a small community made up of helpful, friendly and motivated investors and traders of all levels looking to reach the same goal – the ability to invest profitably in order to achieve financial independence.

Investors of ALL experience levels are welcome.

Join Get Irked by clicking here!

Disclaimer: Eric “Irk” Jacobson and all other Get Irked contributors are not investment or financial advisers. All strategies, trading ideas, and other information presented comes from non-professional, amateur investors and traders sharing techniques and ideas for general information purposes. As always, all individuals should consult their financial advisers to determine if an investing idea is right for them. All investing comes with levels of risk with some ideas and strategies carrying more risk than others. As an individual investor, you are accountable for assessing all risk to determine if the strategy or idea fits with your investment style. All information on Get Irked is presented for educational and informational purposes only.